AMERICA'S BIOPHARMACEUTICAL COMPANIES

Serial Number 87347024
Registration 6329053
700

Registration Progress

Application Filed
Feb 23, 2017
Under Examination
Feb 20, 2018
Approved for Publication
Dec 26, 2017
Published for Opposition
Dec 26, 2017
Registered
Apr 20, 2021

Trademark Image

AMERICA'S BIOPHARMACEUTICAL COMPANIES

Basic Information

Serial Number
87347024
Registration Number
6329053
Filing Date
February 23, 2017
Registration Date
April 20, 2021
Published for Opposition
December 26, 2017
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 20, 2021
Registration
Registered
Classes
042

Rights Holder

Pharmaceutical Research and Manufacturers of America

03
Address
670 Maine Ave. SW
Suite 1000
Washington, DC 20024

Ownership History

Pharmaceutical Research and Manufacturers of America

Original Applicant
03
Washington, DC

Pharmaceutical Research and Manufacturers of America

Owner at Publication
03
Washington, DC

Pharmaceutical Research and Manufacturers of America

Original Registrant
03
Washington, DC

Legal Representation

Attorney
B. Brett Heavner

USPTO Deadlines

Next Deadline
640 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-20)
Due Date
April 20, 2027
Grace Period Ends
October 20, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Mar 7, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 7, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 7, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 7, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 7, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 20, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 16, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 15, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 12, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 11, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 11, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 5, 2021 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Mar 5, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 5, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 4, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 22, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 22, 2021 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Feb 22, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Feb 22, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 19, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 19, 2021 IUAF S USE AMENDMENT FILED Loading...
Aug 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 9, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 9, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 22, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 22, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 11, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 20, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 16, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 16, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 5, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 5, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 13, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 11, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 11, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 11, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 20, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 26, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 26, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 6, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 15, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 14, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...

Detailed Classifications

Class 042
Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testing
First Use Anywhere: 20170100
First Use in Commerce: 20170100

Additional Information

Design Mark
The mark consists of the white stylized wording "AMERICA'S BIOPHARMACEUTICAL COMPANIES" to the right of a rectangular pattern formed by three rows of tiles of varying lengths. The tiles in the top row are, from left to right, a forest green rectangle and an apple green rectangle. The tiles in the middle row are, from left to right, a kelly green rectangle, a forest green rectangle, and a yellow rectangle. The tiles in the bottom row are, from left to right, an apple green square, a teal rectangle, and a mint green rectangle. The black is not part of the mark and represents background area.
Color Claim
The color(s) green, apple green, kelly green, yellow, teal, mint green, and white is/are claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"AMERICA'S BIOPHARMACEUTICAL COMPANIES"